Back to News
Market Impact: 0.35

If the Fed Hikes Again, These 3 Financial Stocks Should Still Hold Up

Monetary PolicyInterest Rates & YieldsInflationBanking & LiquidityCompany FundamentalsInsuranceConsumer Demand & RetailCorporate Earnings
If the Fed Hikes Again, These 3 Financial Stocks Should Still Hold Up

The article argues that higher Federal Reserve rates could benefit JPMorgan Chase and Progressive, while American Express should be relatively insulated. JPMorgan’s consumer and banking division held nearly $1.1 trillion in deposits at the end of Q1 2026, and Progressive generated just over $900 million in investment income in Q1 2026, both supported by rising rates. Overall, the piece is a bullish rate-hike call for select financial stocks rather than broad market news.

Analysis

The market is still pricing “higher-for-longer” as a blunt negative for financials, but the more interesting dispersion is within the sector: balance-sheet scale and funding mix matter more than the level of rates themselves. JPM is the cleanest beneficiary because deposit beta should lag asset yields, so NII can reprice up faster than funding costs; the risk is not rates but credit, since a slowing economy eventually leaks into charge-offs with a 2-4 quarter lag. PGR’s earnings sensitivity is even more direct because short-duration fixed income can reset quickly, turning rate hikes into an immediate uplift to investable income without requiring underwriting improvement.

AXP is the least rate-sensitive of the three and that is exactly why it can be attractive in a macro scare: its earnings path is more tied to affluent spend resilience than to the policy rate itself. The second-order effect is that if consumer weakness broadens, AXP can actually gain share from mass-market card networks as higher-income cohorts stay transacting while lower-income cohorts retrench. The key watch item is not rates, but whether travel and entertainment spending normalizes slower than expected over the next 6-9 months.

The consensus mistake is treating these names as a homogeneous “long financials” basket. In reality, JPM and PGR are functional duration plays on rate hikes, while AXP is a quality consumption compounder with defensive attributes; the best risk-adjusted expression is likely relative value rather than outright beta. If the market begins to discount a recession instead of inflation, the trade should rotate from rate beneficiaries to balance-sheet quality and fee resilience, with JPM likely holding up better than regionals and PGR better than most insurers with longer-duration portfolios.